Report Detail

Pharma & Healthcare Global Ursodeoxycholic Acid Drug Product Market Insights, Forecast to 2025

  • RnM2953606
  • |
  • 13 March, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
In North America, Epic Pharma is leading manufacturers, Teva, Lannett and Mylan are major suppliers of Ursodeoxycholic Acid Drug Product in USA market. In China, Dr. Falk Pharma is leading manufacturers, In Japan, Mitsubishi Tanabe Pharma is leading manufacturers. In Korea, Daewoong Pharmaceutical is leading manufacturers.
The global Ursodeoxycholic Acid Drug Product market is valued at 970 million US$ in 2018 and will reach 2280 million US$ by the end of 2025, growing at a CAGR of 13.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Ursodeoxycholic Acid Drug Product market based on company, product type, end user and key regions.

This report studies the global market size of Ursodeoxycholic Acid Drug Product in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Ursodeoxycholic Acid Drug Product in these regions.
This research report categorizes the global Ursodeoxycholic Acid Drug Product market by top players/brands, region, type and end user. This report also studies the global Ursodeoxycholic Acid Drug Product market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Dr. Falk Pharma
Daewoong Pharmaceutical
Teva
Epic Pharma
Mitsubishi Tanabe Pharma 
Lannett
Mylan
Bruschettini
Impax
Shanghai Pharma
Grindeks

Market size by Product
Capsule
Tablet
Market size by End User
Gallstone
Hepatopathy
Biliary Disease
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Ursodeoxycholic Acid Drug Product market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Ursodeoxycholic Acid Drug Product market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Ursodeoxycholic Acid Drug Product companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Ursodeoxycholic Acid Drug Product submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Ursodeoxycholic Acid Drug Product are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Ursodeoxycholic Acid Drug Product market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Ursodeoxycholic Acid Drug Product Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Ursodeoxycholic Acid Drug Product Market Size Growth Rate by Product
      • 1.4.2 Capsule
      • 1.4.3 Tablet
    • 1.5 Market by End User
      • 1.5.1 Global Ursodeoxycholic Acid Drug Product Market Size Growth Rate by End User
      • 1.5.2 Gallstone
      • 1.5.3 Hepatopathy
      • 1.5.4 Biliary Disease
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Ursodeoxycholic Acid Drug Product Market Size
      • 2.1.1 Global Ursodeoxycholic Acid Drug Product Revenue 2014-2025
      • 2.1.2 Global Ursodeoxycholic Acid Drug Product Sales 2014-2025
    • 2.2 Ursodeoxycholic Acid Drug Product Growth Rate by Regions
      • 2.2.1 Global Ursodeoxycholic Acid Drug Product Sales by Regions
      • 2.2.2 Global Ursodeoxycholic Acid Drug Product Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Ursodeoxycholic Acid Drug Product Sales by Manufacturers
      • 3.1.1 Ursodeoxycholic Acid Drug Product Sales by Manufacturers
      • 3.1.2 Ursodeoxycholic Acid Drug Product Sales Market Share by Manufacturers
      • 3.1.3 Global Ursodeoxycholic Acid Drug Product Market Concentration Ratio (CR5 and HHI)
    • 3.2 Ursodeoxycholic Acid Drug Product Revenue by Manufacturers
      • 3.2.1 Ursodeoxycholic Acid Drug Product Revenue by Manufacturers (2014-2019)
      • 3.2.2 Ursodeoxycholic Acid Drug Product Revenue Share by Manufacturers (2014-2019)
    • 3.3 Ursodeoxycholic Acid Drug Product Price by Manufacturers
    • 3.4 Ursodeoxycholic Acid Drug Product Manufacturing Base Distribution, Product Types
      • 3.4.1 Ursodeoxycholic Acid Drug Product Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Ursodeoxycholic Acid Drug Product Product Type
      • 3.4.3 Date of International Manufacturers Enter into Ursodeoxycholic Acid Drug Product Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Ursodeoxycholic Acid Drug Product Sales by Product
    • 4.2 Global Ursodeoxycholic Acid Drug Product Revenue by Product
    • 4.3 Ursodeoxycholic Acid Drug Product Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Ursodeoxycholic Acid Drug Product Breakdown Data by End User

    6 North America

    • 6.1 North America Ursodeoxycholic Acid Drug Product by Countries
      • 6.1.1 North America Ursodeoxycholic Acid Drug Product Sales by Countries
      • 6.1.2 North America Ursodeoxycholic Acid Drug Product Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Ursodeoxycholic Acid Drug Product by Product
    • 6.3 North America Ursodeoxycholic Acid Drug Product by End User

    7 Europe

    • 7.1 Europe Ursodeoxycholic Acid Drug Product by Countries
      • 7.1.1 Europe Ursodeoxycholic Acid Drug Product Sales by Countries
      • 7.1.2 Europe Ursodeoxycholic Acid Drug Product Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Ursodeoxycholic Acid Drug Product by Product
    • 7.3 Europe Ursodeoxycholic Acid Drug Product by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Ursodeoxycholic Acid Drug Product by Countries
      • 8.1.1 Asia Pacific Ursodeoxycholic Acid Drug Product Sales by Countries
      • 8.1.2 Asia Pacific Ursodeoxycholic Acid Drug Product Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Ursodeoxycholic Acid Drug Product by Product
    • 8.3 Asia Pacific Ursodeoxycholic Acid Drug Product by End User

    9 Central & South America

    • 9.1 Central & South America Ursodeoxycholic Acid Drug Product by Countries
      • 9.1.1 Central & South America Ursodeoxycholic Acid Drug Product Sales by Countries
      • 9.1.2 Central & South America Ursodeoxycholic Acid Drug Product Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Ursodeoxycholic Acid Drug Product by Product
    • 9.3 Central & South America Ursodeoxycholic Acid Drug Product by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Ursodeoxycholic Acid Drug Product by Countries
      • 10.1.1 Middle East and Africa Ursodeoxycholic Acid Drug Product Sales by Countries
      • 10.1.2 Middle East and Africa Ursodeoxycholic Acid Drug Product Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Ursodeoxycholic Acid Drug Product by Product
    • 10.3 Middle East and Africa Ursodeoxycholic Acid Drug Product by End User

    11 Company Profiles

    • 11.1 Dr. Falk Pharma
      • 11.1.1 Dr. Falk Pharma Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Dr. Falk Pharma Ursodeoxycholic Acid Drug Product Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Dr. Falk Pharma Ursodeoxycholic Acid Drug Product Products Offered
      • 11.1.5 Dr. Falk Pharma Recent Development
    • 11.2 Daewoong Pharmaceutical
      • 11.2.1 Daewoong Pharmaceutical Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Product Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Product Products Offered
      • 11.2.5 Daewoong Pharmaceutical Recent Development
    • 11.3 Teva
      • 11.3.1 Teva Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Teva Ursodeoxycholic Acid Drug Product Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Teva Ursodeoxycholic Acid Drug Product Products Offered
      • 11.3.5 Teva Recent Development
    • 11.4 Epic Pharma
      • 11.4.1 Epic Pharma Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Epic Pharma Ursodeoxycholic Acid Drug Product Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Epic Pharma Ursodeoxycholic Acid Drug Product Products Offered
      • 11.4.5 Epic Pharma Recent Development
    • 11.5 Mitsubishi Tanabe Pharma
      • 11.5.1 Mitsubishi Tanabe Pharma Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Product Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Product Products Offered
      • 11.5.5 Mitsubishi Tanabe Pharma Recent Development
    • 11.6 Lannett
      • 11.6.1 Lannett Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Lannett Ursodeoxycholic Acid Drug Product Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Lannett Ursodeoxycholic Acid Drug Product Products Offered
      • 11.6.5 Lannett Recent Development
    • 11.7 Mylan
      • 11.7.1 Mylan Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Mylan Ursodeoxycholic Acid Drug Product Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Mylan Ursodeoxycholic Acid Drug Product Products Offered
      • 11.7.5 Mylan Recent Development
    • 11.8 Bruschettini
      • 11.8.1 Bruschettini Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Bruschettini Ursodeoxycholic Acid Drug Product Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Bruschettini Ursodeoxycholic Acid Drug Product Products Offered
      • 11.8.5 Bruschettini Recent Development
    • 11.9 Impax
      • 11.9.1 Impax Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Impax Ursodeoxycholic Acid Drug Product Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Impax Ursodeoxycholic Acid Drug Product Products Offered
      • 11.9.5 Impax Recent Development
    • 11.10 Shanghai Pharma
      • 11.10.1 Shanghai Pharma Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Shanghai Pharma Ursodeoxycholic Acid Drug Product Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Shanghai Pharma Ursodeoxycholic Acid Drug Product Products Offered
      • 11.10.5 Shanghai Pharma Recent Development
    • 11.11 Grindeks

    12 Future Forecast

    • 12.1 Ursodeoxycholic Acid Drug Product Market Forecast by Regions
      • 12.1.1 Global Ursodeoxycholic Acid Drug Product Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Ursodeoxycholic Acid Drug Product Revenue Forecast by Regions 2019-2025
    • 12.2 Ursodeoxycholic Acid Drug Product Market Forecast by Product
      • 12.2.1 Global Ursodeoxycholic Acid Drug Product Sales Forecast by Product 2019-2025
      • 12.2.2 Global Ursodeoxycholic Acid Drug Product Revenue Forecast by Product 2019-2025
    • 12.3 Ursodeoxycholic Acid Drug Product Market Forecast by End User
    • 12.4 North America Ursodeoxycholic Acid Drug Product Forecast
    • 12.5 Europe Ursodeoxycholic Acid Drug Product Forecast
    • 12.6 Asia Pacific Ursodeoxycholic Acid Drug Product Forecast
    • 12.7 Central & South America Ursodeoxycholic Acid Drug Product Forecast
    • 12.8 Middle East and Africa Ursodeoxycholic Acid Drug Product Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Ursodeoxycholic Acid Drug Product Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Ursodeoxycholic Acid Drug Product . Industry analysis & Market Report on Ursodeoxycholic Acid Drug Product is a syndicated market report, published as Global Ursodeoxycholic Acid Drug Product Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Ursodeoxycholic Acid Drug Product market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,120.00
      4,680.00
      6,240.00
      3,642.60
      5,463.90
      7,285.20
      615,966.00
      923,949.00
      1,231,932.00
      325,377.00
      488,065.50
      650,754.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report